---
title: "Stocks in Play: DRI Healthcare Trust"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291158798.md"
description: "10:07 AM EST - DRI Healthcare Trust : DRI Healthcare Trust (TSX: DHT.UN) today commented on Viridian Therapeutics, Inc.'s recently announced approval by the U.S. Food and Drug Administration of Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease. TED is an autoimmune inflammatory disorder of the orbit (eye socket) that affects numerous patients in the U.S. and can cause debilitating and disfiguring eye symptoms (e.g., inflammation, proptosis, and double-vision) with severe disease leading to vision loss. DRI Healthcare Trust shares T.DHT.UN are trading up $0.66 at $18.11."
datetime: "2026-06-29T14:10:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291158798.md)
  - [en](https://longbridge.com/en/news/291158798.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291158798.md)
generator: "portal-rs"
---

# Stocks in Play: DRI Healthcare Trust

**10:07 AM EST - DRI Healthcare Trust :** DRI Healthcare Trust (TSX: DHT.UN) today commented on Viridian Therapeutics, Inc.'s recently announced approval by the U.S. Food and Drug Administration of Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease. TED is an autoimmune inflammatory disorder of the orbit (eye socket) that affects numerous patients in the U.S. and can cause debilitating and disfiguring eye symptoms (e.g., inflammation, proptosis, and double-vision) with severe disease leading to vision loss. DRI Healthcare Trust shares T.DHT.UN are trading **up $0.66** at $18.11.

### Related Stocks

- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)

## Related News & Research

- [Squarepoint Ops LLC Purchases 133,046 Shares of Viridian Therapeutics, Inc. $VRDN](https://longbridge.com/en/news/298825537.md)
- [12:25 ETRaymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)](https://longbridge.com/en/news/292931199.md)
- [Yarrow Bioscience Updates Strategy for Thyroid Autoimmune Pipeline](https://longbridge.com/en/news/298642695.md)
- [Public Employees Retirement System of Ohio Invests $1.44 Million in DHT Holdings, Inc. $DHT](https://longbridge.com/en/news/298280636.md)
- [DHT Holdings (DHT) Faces Dividend Durability Questions As Valuation Looks Fully Valued](https://longbridge.com/en/news/298240860.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**